New York State Teachers Retirement System Decreases Holdings in Tenet Healthcare Corporation $THC

New York State Teachers Retirement System reduced its stake in Tenet Healthcare Corporation (NYSE:THC) by 3.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,502 shares of the company’s stock after selling 3,228 shares during the period. New York State Teachers Retirement System owned approximately 0.10% of Tenet Healthcare worth $16,513,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. NewEdge Advisors LLC raised its stake in shares of Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after purchasing an additional 166 shares during the period. Jones Financial Companies Lllp increased its holdings in Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after purchasing an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at approximately $290,000. Quantbot Technologies LP acquired a new stake in shares of Tenet Healthcare during the second quarter worth approximately $65,000. Finally, Amundi increased its stake in shares of Tenet Healthcare by 4,207.8% in the second quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after buying an additional 26,383 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the sale, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This represents a 25.12% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.97% of the stock is owned by corporate insiders.

Tenet Healthcare Price Performance

THC opened at $204.28 on Friday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The company’s 50-day moving average price is $181.48 and its 200 day moving average price is $197.31. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The firm has a market cap of $17.60 billion, a price-to-earnings ratio of 10.62, a price-to-earnings-growth ratio of 1.68 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.Tenet Healthcare’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts expect that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on THC. KeyCorp reduced their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Mizuho upped their target price on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday, March 12th. Weiss Ratings cut shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd. Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Finally, Guggenheim reduced their target price on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Eighteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus target price of $244.32.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.